A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round. . . . → Read More: Hydrogel Biomaterials Company Raises $3M in Early Funds
|
|||||
A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round. . . . → Read More: Hydrogel Biomaterials Company Raises $3M in Early Funds A digital health company is asking for FDA authorization to market a mobile app that helps treat type 2 diabetes with cognitive behavioral therapy. . . . → Read More: FDA Clearance Requested for Behavioral Diabetes Therapy A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine. . . . → Read More: Challenge Seeks Animal-Free Testing for Precision Meds. An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins. . . . → Read More: Trial Okayed for Engineered Cell Cancer Therapy The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS. . . . → Read More: FDA Issues Action Plan for Rare Neuro Diseases A retail drugstore chain is offering its store locations and online facilities to help recruit a more diverse patient population for clinical trials. . . . → Read More: Walgreens to Aid Recruitment for Clinical Trials A clinical trial is set to begin assessing an electronic capsule designed to detect and transmit images from the gut to detect early cancer-causing polyps. . . . → Read More: Trial Set for Ingested Colon Cancer Detection Capsule A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile. . . . → Read More: Trial Set for Gut Infection Biologic Treatment A clinical trial is about to begin enrolling participants to test a vaccine given as a nasal spray protecting against respiratory syncytial virus, or RSV. . . . → Read More: Trial Set for Respiratory Disease Nasal Spray Vaccine |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |